Peer-reviewed veterinary case report
Heart disease risk linked to A31P gene in Maine Coon cats
By Granström, S et al.·Published in Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2015·Department of Veterinary Clinical and Animal Sciences·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study.
- Species:
- cat
Plain-English summary
A group of Maine Coon cats was studied to understand how a specific genetic mutation (A31P) affects heart health, particularly hypertrophic cardiomyopathy (HCM), which is a serious heart condition. Among the cats, 6.4% were diagnosed with HCM at the start, and over time, an additional 6.7% developed the condition. Cats with two copies of the mutation had a much higher risk, with 80% developing HCM and nearly half experiencing cardiac death during the study. This highlights the importance of genetic testing for Maine Coons to monitor heart health closely.
People also search for: Maine Coon heart disease · cat hypertrophic cardiomyopathy symptoms · A31P mutation in cats
Abstract
OBJECTIVES: A missense mutation (A31P) in the cardiac myosin binding protein C gene has been associated with hypertrophic cardiomyopathy (HCM) in Maine Coon cats. The aim of this study was to investigate the effect of A31P on development of HCM, myocardial diastolic dysfunction detected by color tissue Doppler imaging and occurrence of cardiac death during longitudinal follow-up in a cohort of Maine Coon cats. ANIMALS: The original cohort comprised 282 cats (158 of wild-type genotype, 99 heterozygous for A31P and 25 homozygous for A31P). METHODS: Prospective longitudinal study including echocardiography and registration of survival. RESULTS: The median age at the initial examination was 1.7 years (range, 0.8-9.2 years) and 6.4% (18/282) of the cats were diagnosed with HCM. One hundred sixty-five cats were eligible for echocardiographic re-examination, and during an average follow-up period of 2.7 years an additional 6.7% (11/165) of the cats developed HCM. Survival data could be obtained for 262 of the cats originally included, and among these 9.2% (24/262) died of causes that met the study criteria for cardiac death. In the homozygous group 80% (20/25) of cats included were diagnosed with HCM and 48% (12/25) suffered cardiac death during follow-up. These results corresponded to a significantly higher risk for cats homozygous for A31P to develop HCM (p<0.001) and die from cardiac-related causes compared with both other genotypes (p<0.001). CONCLUSIONS: Homozygosity for A31P was associated with a high penetrance of HCM and a substantial risk for cardiac death in the study population.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26776585/